Epidemiological, Therapeutic and Evolutive Aspects of Bladder Cancer in Douala

Engbang, Jean Paul; Moby, H; Soumaï, Falonne Daoudou; Amougou, Boris; Nwaha, Makon; Ngowe, Marcelin Ngowe

doi:10.26502/anu.2644-2833048

Arch Nephrol Urol

2022

DOI: 10.26502/anu.2644-2833048

|View full text |Cite

Epidemiological, Therapeutic and Evolutive Aspects of Bladder Cancer in Douala

Jean Paul Engbang¹,

H Moby²,

Falonne Daoudou Soumaï³

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

PSCA gene expression in bladder, colorectal and prostate cancer patients from Basrah governorate southern of Iraq

Ayoob,

Al-Badran,

Abood

2024

APJMBB

View full text Add to dashboard Cite

Cancer causes death in all countries of the world, with approximately (9.6) million deaths in 2018. Developing countries have high cancer rates. Furthermore, there are risk factors that lead to cancer, including economic and political instability and bad lifestyles. This is the first study of PSCA gene expression with BC, CRC and PC in Iraq, especially in Basrah governorate. This paper involved one hundred and one blood samples being collected from bladder, colorectal and prostate cancer. On the other hand, one hundred and one blood samples with no cancer were collected as a control group. Two ml of peripheral blood was drawn for RNA extraction, then total RNA was reverse transcribed to cDNA, and PSCA mRNA was measured using qPCR. The results showed PSCA gene was over expressed in bladder cancer (BC) with an expression level at ± 8.63 for patients and controls estimated with ±4.16. The gene expression was a 2-fold change in patients compared to healthy control. While the PSCA gene was over-expressed in colorectal cancer (CRC) with an expression level ± 8.16 for patients and controls estimated at ±3.30. That means the gene expression was a 2.47-fold change in patients compared to healthy control. The PSCA gene was over expressed in prostate cancer (PC) with an expression level ± 9.47 for patients and controls estimated at ±4.22. The gene expression was a 2.24-fold change in patients compared to healthy control. In the present study, PSCA gene was expressed at a significantly higher level in the BC, CRC and PC patients compared in the controls group.

show abstract

PSCA gene expression in bladder, colorectal and prostate cancer patients from Basrah governorate southern of Iraq

Ayoob,

Al-Badran,

Abood

2024

APJMBB

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Epidemiological, Therapeutic and Evolutive Aspects of Bladder Cancer in Douala

Cited by 1 publication

References 0 publications

PSCA gene expression in bladder, colorectal and prostate cancer patients from Basrah governorate southern of Iraq

PSCA gene expression in bladder, colorectal and prostate cancer patients from Basrah governorate southern of Iraq

Contact Info

Product

Resources

About